Association between cytokine profile and transcription factors produced by T-cell subsets in early- and late-onset pre-eclampsia

Immunology

Volumn 152, Issue 1, 2017, Pages 163-173

  Ribeiro, Vanessa R ^a   Romao Veiga, Mariana ^a   Romagnoli, Graziela G ^a   Matias, Mariana L ^a   Nunes, Priscila R ^a   Borges, Vera Therezinha M ^a   Peracoli, Jose C ^a   Peracoli, Maria Terezinha S ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

cytokines; regulatory T cells; reproductive immunology; T cells; transcription factors

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; AUTACOID; BIOLOGICAL MARKER; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; GATA3 PROTEIN, HUMAN; MESSENGER RNA; RORC PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EARLY ONSET PRE ECLAMPSIA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; HUMAN CELL; LATE ONSET PRE ECLAMPSIA; MATERNAL AGE; PERIPHERAL LYMPHOCYTE; POLARIZATION; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEINURIA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SYSTOLIC BLOOD PRESSURE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; BLOOD; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHENOTYPE; PRE-ECLAMPSIA; PREGNANCY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PHENOTYPE; PRE-ECLAMPSIA; PREGNANCY; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 85020536083     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12757     Document Type: Article

References (59)

1. ACOG Practice Bulletin no. 33. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002; 99:159–67.
2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365:785–99.
3. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol 2012; 36:56–9.
4. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183:S1–22.
5. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens 2014; 4:97–104.
6. Mol BW, Roberts CT, Thangaratinam S, Magee LA, de Groot CJ, Hofmeyr GJ. Pre-eclampsia. Lancet 2016; 387:999–1011.
7. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003; 22:143–8.
8. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008; 51:970–5.
9. Murphy DJ, Stirrat GM. Mortality and morbidity associated with early-onset preeclampsia. Hypertens Pregnancy 2000; 19:221–31.
10. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195:40–9.
11. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308:1592–4.
12. Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv 2011; 66:497–506.
13. Lok CA, Jebbink J, Nieuwland R, Faas MM, Boer K, Sturk A et al. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am J Reprod Immunol 2009; 61:346–59.
14. Luppi P, Deloia JA. Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 2006; 118:268–75.
15. Peraçoli MT, Bannwart CF, Cristofalo R, Borges VT, Costa RA, Witkin SS et al. Increased reactive oxygen species and tumor necrosis factor-α production by monocytes are associated with elevated levels of uric acid in pre-eclamptic women. Am J Reprod Immunol 2011; 66:460–7.
16. Raghupathy R. Cytokines as key players in the pathophysiology of preeclampsia. Med Princ Pract 2013; 22:8–19.
17. Cristofalo R, Bannwart-Castro CF, Magalhães CG, Borges VT, Peraçoli JC, Witkin SS et al. Silibinin attenuates oxidative metabolism and cytokine production by monocytes from preeclamptic women. Free Radic Res 2013; 47:268–75.
18. Peraçoli JC, Bannwart-Castro CF, Romao M, Weel IC, Ribeiro VR, Borges VT et al. High levels of heat shock protein 70 are associated with pro-inflammatory cytokines and may differentiate early- from late-onset preeclampsia. J Reprod Immunol 2013; 100:129–34.
19. + regulatory T cells and inducing indoleamine 2,3-dioxygenase. J Reprod Immunol 2009; 80:1–11.
20. Jimeno R, Leceta J, Garin M, Ortiz AM, Mellado M, Rodriguez-Frade JM et al. Th17 polarization of memory Th cells in early arthritis: the vasoactive intestinal peptide effect. J Leukoc Biol 2015; 98:257–69.
21. Conforti-Andreoni C, Spreafico R, Qian HL, Riteau N, Ryffel B, Ricciardi-Castagnoli P et al. Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18. J Immunol 2011; 187:5842–50.
22. Peck A, Mellins ED. Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 2010; 129:147–53.
23. Figueiredo AS, Schumacher A. The T helper type 17/regulatory T cell paradigm in pregnancy. Immunology 2016; 148:13–21.
24. Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 2010; 159:109–19.
25. + regulatory T cells. Nat Immunol 2003; 4:330–6.
26. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057–61.
27. Jianjun Z, Yali H, Zhiqun W, Mingming Z, Xia Z. Imbalance of T-cell transcription factors contributes to the Th1 type immunity predominant in pre-eclampsia. Am J Reprod Immunol 2010; 63:38–45.
28. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010; 63:601–10.
29. + T cell differentiation. Postepy Hig Med Dosw 2011; 65:414–26.
30. Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003; 59:161–73.
31. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol 2012; 93:75–81.
32. + T cells in healthy pregnancy but not in preeclampsia. J Immunol 2009; 183:7023–30.
33. Matias ML, Romão M, Weel IC, Ribeiro VR, Nunes PR, Borges VT et al. Endogenous and uric acid-induced activation of NLRP3 inflammasome in pregnant women with preeclampsia. PLoS One 2015; 10:e0129095.
34. Larionov A, Krause A, Miller W. A standard curve based method for relative real time PCR data processing. BMC Bioinformatics 2005; 6:62.
35. Gervasi MT, Chaiworapongsa T, Pacora P, Naccasha N, Yoon BH, Maymon E et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol 2001; 185:792–7.
36. bright regulatory T cells in pre-eclampsia. Clin Exp Immunol 2007; 149:139–45.
37. Prins JR, Boelens HM, Heimweg J, Van der Heide S, Dubois AE, Van Oosterhout AJ et al. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens Pregnancy 2009; 28:300–11.
38. + regulatory T cells in normal pregnancy and pre-eclampsia. Am J Reprod Immunol 2012; 68:175–80.
39. Hafeez NA, Fouda Mel-T, Abdel Gawad ER, Assar T, Mansour AI. The role of regulatory T cells in preeclampsia. Egypt J Immunol 2014; 21:45–55.
40. Cao W, Wang X, Chen T, Zhu H, Xu W, Zhao S et al. The expression of notch/notch ligand, IL-35, IL-17, and Th17/Treg in preeclampsia. Dis Markers 2015; 2015:316182.
41. Gharesi-Fard B, Mobasher-Nejad F, Nasri F. The expression of T-helper associated transcription factors and cytokine genes in pre-eclampsia. Iran J Immunol 2016; 13:296–308.
42. Alijotas-Reig J, Llurba E, Gris JM. Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells. Placenta 2014; 35:241–8.
43. Zhang Z, Liu H, Shi Y, Xu N, Wang Y, Li A et al. Increased circulating Th22 cells correlated with Th17 cells in patients with severe preeclampsia. Hypertens Pregnancy 2016; 11:1–8.
44. Ozkan ZS, Simsek M, Ilhan F, Deveci D, Godekmerdan A, Sapmaz E. Plasma IL-17, IL-35, interferon-γ, SOCS3 and TGF-β levels in pregnant women with preeclampsia, and their relation with severity of disease. J Matern Fetal Neonatal Med 2014; 27:1513–7.
45. Barnie PA, Lin X, Liu Y, Xu H, Su Z. IL-17 producing innate lymphoid cells 3 (ILC3) but not Th17 cells might be the potential danger factor for preeclampsia and other pregnancy associated diseases. Int J Clin Exp Pathol 2015; 8:11100–7.
46. Beckmann I, Efraim SB, Vervoort M, Visser W, Wallenburg HC. Tumor necrosis factor-α in whole blood cultures of preeclamptic patients and healthy pregnant and nonpregnant women. Hypertens Pregnancy 2004; 23:319–29.
47. Peraçoli JC, Rudge MV, Peraçoli MT. Tumor necrosis factor-α in gestation and puerperium of women with gestational hypertension and pre-eclampsia. Am J Reprod Immunol 2007; 57:177–85.
48. Tarnowska-Madra U, Leibschang J, Kowalska B, Filipp E, Kozar A, Maciejewski T. Levels of cytokines in serum of women with preeclampsia or severe pregnancy hypertension. Ginekol Pol 2010; 81:192–6.
49. Molvarec A, Czegle I, Szijártó J, Rigó J Jr. Increased circulating interleukin-17 levels in preeclampsia. J Reprod Immunol 2015; 112:53–7.
50. Xu L, Lee M, Jeyabalan A, Roberts JM. The relationship of hypovitaminosis D and IL-6 in preeclampsia. Am J Obstet Gynecol 2014; 210:149.
51. Weaver CT, Hatton RD. Interplay between the TH17 and Treg cell lineages: a (co)evolutionary perspective. Nat Rev Immunol 2009; 9:883–9.
52. Afzali B, Mitchell P, Lechler RI, John S, Lombardi G. Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol 2010; 159:120–30.
53. Rahimzadeh M, Norouzian M, Arabpour F, Naderi N. Regulatory T-cells and preeclampsia: an overview of literature. Expert Rev Clin Immunol 2016; 12:209–27.
54. 1 and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation? Placenta 2002; 23:380–5.
55. + T cell-mediated suppression by dendritic cells. Science 2003; 299:1033–6.
56. Cemgil Arikan D, Aral M, Coskun A, Ozer A. Plasma IL-4, IL-8, IL-12, interferon-γ and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight. J Matern Fetal Neonatal Med 2012; 25:1569–73.
57. Azizieh F, Raghupathy R, Makhseed M. Maternal cytokine production patterns in women with pre-eclampsia. Am J Reprod Immunol 2005; 54:30–7.
58. Borekci B, Aksoy H, Al RA, Demircan B, Kadanali S. Maternal serum interleukin-10, interleukin-2 and interleukin-6 in pre-eclampsia and eclampsia. Am J Reprod Immunol 2007; 58:56–64.
59. van Rijn BB, Franx A, Steegers EA, de Groot CJ, Bertina RM, Pasterkamp G et al. Maternal TLR4 and NOD2 gene variants, pro-inflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome. PLoS One 2008; 3:e1865.